Catalyst Wire Dossier Catalyst Wire Dossier

ASP1707

· Astellas Pharma Inc.
Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for ASP1707, covering 2014-04-08 to 2024-10-23. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Assess the Effectiveness and Safety of Different Doses of ASP1707 Compared to Placebo for Endometriosis Associated Pelvic Pain [Phase 2]

See pricing